EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

LINC00629 , a HOXB4 ‐downregulated long noncoding RNA , inhibits glycolysis and ovarian cancer progression by destabilizing c‐Myc

Jia Liu, Yuan Zhu, Huan Wang, Chuanchun Han, Yongpeng Wang, Ranran Tang iD

Cancer Science · 2024

DOI: 10.1111/cas.16049 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Science, 2024. Verfasst von Jia Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shenyang, China. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Mouth Neoplasms, Ovarian Neoplasms, RNA, Long Noncoding. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Nanjing Municipal Health Technology Development Special, Nanjing Municipal Health Technology Development Special Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ovarian cancer (OC) cells typically reprogram their metabolism to promote rapid proliferation. However, the role of long noncoding RNAs (lncRNAs) in the metabolic reprogramming of ovarian cancer, especially in glucose metabolic reprogramming, remains largely unknown. LINC00629 has been reported in our previous study to promote osteosarcoma progression. Upregulated LINC00629 was found to enhance the growth‐suppressive effect of apigenin on oral squamous cell carcinoma. However, the precise function of LINC00629 in ovarian cancer development remains poorly understood. In this study, we found that LINC00629 was significantly downregulated in OC tissues and that low LINC00629 expression was associated with poor survival. Inhibition of LINC00629 was required for increased glycolysis activity and cell proliferation in ovarian cancer. In vivo, overexpression of LINC00629 dramatically inhibited tumor growth and lung metastasis. Mechanistically, LINC00629 interacted with and destabilized c‐Myc, leading to its ubiquitination and proteasome degradation, further resulting in increased expression of downstream glycolysis‐related genes and glucose metabolic reprogramming in OC. Interestingly, HOXB4 bound to the LINC00629 promoter and inhibited its transcription, indicating that LINC00629 is a transcriptional target of HOXB4. Collectively, these findings establish a direct role for LINC00629 in suppressing glucose metabolism, and HOXB4/LINC00629/c‐Myc might serve as a potential biomarker and an effective therapeutic strategy for OC cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Squamous CellMouth NeoplasmsOvarian NeoplasmsRNA, Long NoncodingFemaleHumansCell Line, TumorCell ProliferationGene Expression Regulation, NeoplasticGlucoseGlycolysisHomeodomain ProteinsTranscription FactorsProto-Oncogene Proteins c-myc

Stichwörter der Autor:innen

HOXB4LINC00629c-Mycglycolysisovarian cancer

Substanzen

GlucoseHomeodomain ProteinsRNA, Long NoncodingTranscription FactorsHOXB4 protein, humanlong non-coding RNA LINC00629, humanMYC protein, humanProto-Oncogene Proteins c-myc

Autor:innen und Institutionen

  • Department of Gynecology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shenyang, China.
  • Department of Gynecology, Women's Hospital of Nanjing Medical University, Nanjing Women and Children's Healthcare Hospital, Nanjing, China.
  • The Second Affiliated Hospital and Institute of Cancer Stem Cell, Dalian Medical University, Dalian, Liaoning, China.

ORCID-Profile: Ranran Tang

Förderung

  • Nanjing Municipal Health Technology Development Special
  • Nanjing Municipal Health Technology Development Special Fund

Zitieren

APA

Liu, J., Zhu, Y., Wang, H., Han, C., Wang, Y., & Tang, R. (2024). LINC00629 , a HOXB4 ‐downregulated long noncoding RNA , inhibits glycolysis and ovarian cancer progression by destabilizing c‐Myc. Cancer Science. https://doi.org/10.1111/cas.16049

Vancouver

Liu J, Zhu Y, Wang H, Han C, Wang Y, Tang R. LINC00629 , a HOXB4 ‐downregulated long noncoding RNA , inhibits glycolysis and ovarian cancer progression by destabilizing c‐Myc. Cancer Science. 2024. doi:10.1111/cas.16049

BibTeX
@article{Liu2024,
  author = {Liu, Jia and Zhu, Yuan and Wang, Huan and Han, Chuanchun and Wang, Yongpeng and Tang, Ranran},
  title = {LINC00629 , a HOXB4 ‐downregulated long noncoding RNA , inhibits glycolysis and ovarian cancer progression by destabilizing c‐Myc},
  journal = {Cancer Science},
  year = {2024},
  doi = {10.1111/cas.16049}
}
Kostenlos starten →